Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation

Acta Ophthalmologica

Volumn 91, Issue 3, 2013, Pages 267-273

  Parodi, Maurizio B ^a   Iacono, Pierluigi ^b   Menchini, Francesca ^c   Sheth, Saumil ^a   Polini, Giovanni ^c   Pittino, Raffaele ^c   Bandello, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

age related macular degeneration; bevacizumab; ranibizumab; retinal angiomatous proliferation

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

AGED; ARTICLE; CENTRAL MACULAR THICKNESS; CLINICAL EVALUATION; CONFOCAL SCANNING LASER OPHTHALMOSCOPE; CONTROLLED STUDY; CORNEA LIMBUS; DISEASE COURSE; DRUG EFFICACY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEOVASCULARIZATION (PATHOLOGY); OPHTHALMOLOGY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; RETINA DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA TEAR; RETINAL ANGIOMATOUS PROLIFERATION; SNELLEN CHART; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANGIOMATOSIS; ANTIBODIES, MONOCLONAL, HUMANIZED; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INDOCYANINE GREEN; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL NEOVASCULARIZATION; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84876413362     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2011.02265.x     Document Type: Article

References (32)

1. Boscia F, Furino C, Sbornia L, et al., (2004): Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 138: 1077-1079.
2. Boscia F, Parodi MB, Furino C, et al., (2006): Photodynamic therapy with verteporfin for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 244: 1224-1232.
3. Bottoni F, Massacesi A, Cigada M, et al., (2005): Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 123: 1644-1650.
4. CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, &, Jaffe GJ., (2011): Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364: 1897-1908.
5. Costagliola C, Romano MR, Dell'Omo R, Cipollone U, &, Polisena P., (2007): Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation. Am J Ophthalmol 144: 449-451.
6. Freund KB, Klais CM, Eandi CM, et al., (2006): Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 124: 487-492.
7. Gass JD, Agarwal A, Lavina AM, &, Tawansy KA., (2003): Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 23: 741-751.
8. Gharbiya M, Allievi F, Recupero V, Martini D, Mazzeo L, &, Gabrieli CB., (2009): Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results. Retina 29: 740-749.
9. Ghazi NG, Knape RM, Kirk TQ, Tiedeman JS, &, Conway BP., (2008): Intravitreal bevacizumab (avastin) treatment of retinal angiomatous proliferation. Retina 28: 689-695.
10. Hemeida TS, Keane PA, Dustin L, Sadda SR, &, Fawzi AA, (2010): Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation. Br J Ophthalmol 94: 701-705.
11. Joeres S, Heussen FM, Treziak T, Bopp S, &, Joussen AM., (2007): Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 245: 1597-1602.
12. Johnson TM, &, Glaser BM., (2006): Focal laser ablation of retinal angiomatous proliferation. Retina 26: 765-772.
13. Konstantinidis L, Mameletzi E, Mantel I, Pournaras JA, Zografos L, &, Ambresin A., (2009): Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP). Graefes Arch Clin Exp Ophthalmol 247: 1165-1171.
14. Krebs I, Krepler K, Stolba U, et al., (2008): Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone. Graefes Arch Clin Exp Ophthalmol 246: 237-243.
15. Lai TYY, Chan WM, Liu DT, &, Lam DS., (2007): Ranibizumab for retinal angiomatos proliferation in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245: 1877-1880.
16. Meyerle CB, Freund KB, Iturralde D, et al., (2007): Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 27: 451-457.
17. Monson DM, Smith JR, Klein ML, &, Wilson DJ., (2008): Clinopathologic correlation of retinal angiomatous proliferation. Arch Ophthalmol 126: 1664-1668.
18. Montero JA, Fernandez MI, Gomez-Ulla F, &, Ruiz-Moreno JM, (2009): Efficacy of intravitreal bevacizumab to treat retinal angiomatous proliferation stage II and III. Eur J Ophthalmol 19: 448-451.
19. Panagiotidis D, Karagiannis DA, &, Baltatzis S., (2006): Photodynamic therapy in retinal angiomatous proliferation Stage I. Eur J Ophthalmol 16: 326-329.
20. Reche-Frutos J, Calvo-Gonzalez C, Donate-Lopez J, et al., (2007): Retinal angiomatous proliferation reactivation 6 months after high-dose intravitreal acetonide triamcinolone and photodynamic therapy. Eur J Ophthalmol 17: 979-982.
21. Rouvas AA, Papakostas TD, Vavvas D, Vergados I, Moschos MM, Kotsolis A, &, Ladas ID., (2009): Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. Retina 29: 536-544.
22. Sakimoto S, Gomi F, Sakaguchi H, &, Tano Y., (2005): Recurrent retinal angiomatous proliferation after surgical ablation. Am J Ophthalmol 139: 917-918.
23. Shimada H, Kawamura A, Mori R, &, Yuzawa M., (2007): Clinicopathological findings of retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 245: 295-300.
24. Shiragami C, Iida T, Nagayama D, et al., (2007): Recurrence after surgical ablation for retinal angiomatous proliferation. Retina 27: 198-203.
25. Silva RM, Faria de Abreu JR, Travassos A, &, Cunha-Vaz JG., (2004): Stabilization of visual acuity with photodynamic therapy in eyes with chorioretinal anastomoses. Graefes Arch Clin Exp Ophthalmol 242: 368-376.
26. Silva RM, Cachulo ML, Figueira J, et al., (2007): Chorioretinal anastomosis and photodynamic therapy: a two-year follow-up study. Graefes Arch Clin Exp Ophthalmol 245: 1131-1139.
27. Slakter JS, Yannuzzi LA, Schneider U, et al., (2000): Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 107: 742-753.
28. Spaide RF, Sorenson J, &, Maranan L., (2003): Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularisation. Ophthalmology 110: 1517-1525.
29. Spaide RF, Sorenson J, &, Maranan L., (2005): Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112: 301-304.
30. Van de Moere A, Kak R, Sandhu SS, &, Talks SJ., (2007): Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone. Am J Ophthalmol 143: 701-704.
31. Viola F, Massacesi A, Orzalesi N, Ratiglia R, &, Staurenghi G., (2009): Retinal angiomatous proliferation: natural history and progression of visual loss. Retina 29: 732-739.
32. Yannuzzi LA, Negrao S, Iida T, et al., (2001): Retinal angiomatous proliferation in age-related macular degeneration. Retina 21: 416-434.